TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 1 | 12 | -37 | -51 | -68 | -71 | -36 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/31/16 15:15 | 3/29/16 | ULUR | Uluru Inc. | NV | Health | Drug | Pharmaceutical Preparations | Wallberg Terrance K | TX | DO | CFO | P.d | 50 | 0.0713 | 0 | 701 | 564 | 826 | D | ||||||||||||||
3/15/13 18:01 | 3/14/13 | ULUR | Uluru Inc. | NV | Health | Drug | Pharmaceutical Preparations | Wallberg Terrance K | TX | O | CFO | P.d | 40 | 0.4000 | 0 | 100 | 412 | 124 | D | ||||||||||||||
10/9/08 10:44 | 10/8/08 | ULU | Uluru Inc. | NV | Health | Drug | Pharmaceutical Preparations | Wallberg Terrance K | TX | O | CFO | P | 2 | 0.7500 | 0 | 2 | 1 | 264 | D | -25 | -82 | -63 | -30 | -51 | -34 | -22 | -16 | 1 | 12 | -37 | -51 | -68 | -71 |
1/4/07 16:14 | 11/15/06 | ULUR. | Uluru Inc. | NV | Health | Drug | Pharmaceutical Preparations | Wallberg Terrance K | TX | O | CFO | P | 0 | 0.0100 | 0 | 18 | 8 | 246 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |